Free Trial
BizSense Pro Password

Commonwealth Biotechnologies »

Stalking horse reappears in the homestretch

Michael Schwartz December 7, 2011 0

A three-hour bidding war broke out Tuesday over the former headquarters of a bankrupt local tech company.

Read More »

Stalking horse backs down

Michael Schwartz July 19, 2011 0

The local investment fund that had made a $4 million bid on the last remaining asset of a bankrupt local firm has pulled out.

Read More »

A stalking horse emerges

Michael Schwartz June 13, 2011 0

A Richmond real estate investment fund wants to buy the last remaining asset of a bankrupt local biotech firm.

Read More »

He has had enough

Michael Schwartz March 15, 2011 0

Bill Guo wants shareholders of a bankrupt local biotech firm to change the size of its board to a single director. And you can probably guess who he wants to be No. 1.

Read More »

The Pipeline: Commercial Real Estate Round Up for 4.30.10

Al Harris April 30, 2010 0

Hanover County purchased a 14,400 square feet flex condo unit at 9732-9742 Atlee Commons Road in Hanover for $1.7 million. The Witmeyer Law Firm leased 1,920 square feet at 10035 Sliding Hill Road in

Read More »

Local labs zip up deal

Al Harris November 3, 2009 1

Glen Allen-based Bostwick Laboratories has completed the $1.11 million purchase of two divisions of Commonwealth Biotechnologies of Chesterfield

Read More »

Biotech firm closes China deal

Al Harris September 3, 2009 0

Chesterfield-based Commonwealth Biotechnologies have closed on a deal to merge with a group of Chinese companies

Read More »

Commonwealth Biotechnologies gets delisting warning

Al Harris July 31, 2009 1

Commonwealth Biotechnologies, a Chesterfield-based biotech firm that has made several international deals lately, received a delisting notice from NASDAQ for failure to meet certain filing rules. The stock is down $0.11, or 17 percent,

Read More »

Two local labs sign deal

Al Harris July 22, 2009 0

Chesterfield biotech firm Commonwealth Biotechnologies plans to sell off segments of its business to Bostwick Laboratories, which is based in the West End. Bostwick plans to go public this year

Read More »

Commonwealth Biotechnologies stock surges

Al Harris June 11, 2009 0

Shares of Chesterfield-based Commonwealth Biotechnologies almost doubled Thursday, closing at $0.76 a share. Stocks that trade for less than $1 are notoriously volatile, but this seems to be on account of a deal with

Read More »